Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
Clinical trial NCT05750628 · RECRUITING
Trial details
- NCT number
- NCT05750628
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2026-06-09
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.